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Maternal hypothyroxinemia during early pregnancy poses an increased risk for poor neuropsychological development of the fetus. We tested
the hypothesis that maternal hypothyroidism before the onset of fetal thyroid function also affects postnatal development of heart and lungs. This
question was addressed in transgenic mice that express herpes simplex virus thymidine kinase in their thyroidal follicle cells. Treatment with
ganciclovir rendered these mice severely hypothyroid because viral thymidine kinase converts ganciclovir into a cytotoxic nucleoside analog.
Since ganciclovir crosses the placenta, it also destroyed the thyroid of transgenic embryos while leaving the thyroids of nontransgenic littermates
unaffected. Hypothyroidism of both mother and fetus did not affect prenatal heart and lung development. However, the postnatal switch from h-
to a-myosin heavy chain (h- and a-MHC, respectively) gene expression and the increase of SERCA-2a mRNA expression did not occur in the
ventricular myocardium of either the transgenic (thyroid destroyed) or nontransgenic (intact thyroid) offspring of hypothyroid mothers. Similarly,
postnatal animals of the latter two groups retained elevated surfactant protein (SP) -A, -B, and -C mRNA levels in their alveolar epithelium. In
hypothyroid pups from hypothyroid mothers, these changes were accompanied by decreased alveolar septation. Our study shows that these
effects of maternal hypothyroidism become manifest after birth and are aggravated by the concomitant existence of neonatal hypothyroidism.
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hypothalamic–pituitary–thyroid system matures relatively
late in gestation (Fisher and Klein, 1981; Thorpe-Beeston et
al., 1991). The association of iodine deficiency, causing
hypothyroidism in both mother and fetus, with cretinism is
well established (Delange, 2001). The importance of thyroid
hormone for the developing fetus has nevertheless been
questioned because postnatal substitution of thyroid hormone
almost completely prevents the detrimental effects of con-
genital hypothyroidism (Bongers-Schokking et al., 2000).
Recently, however, the significance of a normal maternal
thyroid-hormone status for proper organ development in the
offspring, in particular that of the brain, has again attracted
attention (Glinoer and Delange, 2000; Haddow et al., 1999;
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shown that the fetal brain was most sensitive to maternal
hypothyroxinemia between the third and fifth month (Fisher
et al., 2000), that is, when the fetal thyroid is not yet
functional.
In addition to the brain, the heart and lungs are known
targets of thyroid hormone. In the heart, thyroid hormone
stimulates the transcription of a-myosin heavy chain (a-
MHC) and inhibits that of h-myosin heavy chain (h-MHC)
(Gustafson et al., 1986; Lompre´ et al., 1984; Mahdavi et al.,
1987). Before birth, the ventricles express high levels of h-
MHC and only low levels of a-MHC; whereas after birth,
the a-MHC level increases and virtually replaces h-MHC
by postnatal day 7 (Lompre´ et al., 1984). The postnatal
increase in a-MHC and decrease in h-MHC expression
have been attributed to the postnatal increase in circulating
thyroid hormone (Chizzonite and Zak, 1984). Similarly, the
sarcoplasmatic reticulum ATPase isoform 2a (SERCA-2a)
and its regulatory subunit phospholamban (PLB) are recip-
rocally regulated by thyroid hormone (Arai et al., 1991; Kiss
et al., 1994; Rohrer and Dillmann, 1988). SERCA-2a and
PLB expression are low in fetal hearts and increase after
birth (Moorman et al., 2000b; Reed et al., 2000). Neonatal
hypothyroidism decreased SERCA-2a levels and increased
cardiac PLB levels, whereas neonatal hyperthyroidism left
SERCA-2a levels unchanged but decreased cardiac PLB
expression (Cernohorsky et al., 1998; Kiss et al., 1994;
Reed et al., 2000).
In perinatal lungs, the postnatal increase in thyroid
hormone availability coincides with the acceleration of
alveolar septation, suggesting that thyroid hormone enhan-
ces the structural development of the lungs (Massaro and
Massaro, 2002). In agreement, the lungs of homozygous
‘‘hyt’’ mice, which suffer from congenital hypothyroidism
due to a mutation in the thyroid-stimulating hormone (TSH)
receptor (Stein et al., 1994), become affected only after birth
(deMello et al., 1994). Lungs of homozygous ‘‘hyt’’ mice
contain less saturated phosphatidylcholine and have thicker
alveolar septa and smaller airspaces than euthyroid litter-
mates (deMello et al., 1994). A role for thyroid hormone in
functional development of the perinatal lung is however
disputed (Moya et al., 1992). Thus, it was both reported that
prenatal thyrotropin-releasing hormone or triiodothyronine
(T3) treatment of fetal rat lungs in vitro or in vivo did not
enhance surfactant protein (SP) A, B, and C expression
(Floros et al., 1991; Nichols et al., 1990; Veletza et al.,
1992; Yokoyama et al., 1995), and that thyroid hormone
stimulated the functional maturation of the surfactant pro-
ducing type II cells of the lungs (Ansari et al., 2000).
However, it was also reported that during early embryonic
lung development, thyroid hormone accelerated epithelial
and mesenchymal cell differentiation at the expense of
branching morphogenesis and lung growth (Archavachoti-
kul et al., 2002), suggesting that an untimely exposure to an
effective level of thyroid hormone can prematurely halt
organogenesis and precipitate functional maturation. Sincethe human fetal lungs express a relatively high level of
thyroid hormone receptors as early as 13 weeks of gestation
(Bernal and Pekonen, 1984; Gonzales and Ballard, 1981),
maternal hypothyroidism in man may also affect fetal lung
development.
Given the effect of maternal hypothyroidism on prenatal
brain development, we hypothesized that maternal hypo-
thyroidism before the onset of fetal thyroid function could
similarly affect heart and/or lung morphogenesis and mat-
uration. In the present study, we have used ‘‘TG-TKT2’’
transgenic mice to experimentally address this question.
TG-TKT2 transgenic mice harbor a construct, consisting of
the bovine thyroglobulin (TG) promoter coupled to the
herpes simplex virus thymidine kinase type 2 (TKT2)
structural gene (Ellison et al., 1995). The thyroglobulin
promoter confers specific expression of the TKT2 gene in
the follicle cells of the thyroid. Because viral thymidine
kinase renders the nucleoside analog ganciclovir cytotoxic
by phosphorylation, treatment of transgenic mice with
ganciclovir causes the specific destruction of these follicle
cells. Since ganciclovir crosses the placenta, it can also be
used to destroy the follicle cells of transgenic embryos
(Wallace et al., 1994, 1995).
We demonstrate that hypothyroidism of both the mother
and the fetus did not affect the parameters investigated
during prenatal myocardial or pulmonary development.
However, the postnatal switch in the heart from h- to a-
MHC gene expression and the increase of SERCA-2a
mRNA expression did not occur in either the transgenic
(thyroid destroyed) or nontransgenic (intact thyroid) off-
spring of hypothyroid dams. Similarly, such pups retained
elevated SP-A, -B, and -C mRNA levels in their alveolar
epithelium, whereas the postnatal hypothyroid pups from
hypothyroid mothers also suffered from impaired morpho-
logical development of the lungs. These results indicate
that an adequate function of the maternal thyroid is
important for normal postnatal development of both heart
and lungs.Materials and methods
Animals
Adult transgenic mice of the TG-TKT2 strain (C57Bl/6
background) were obtained from the AFCR Center for
Genomic Research, University of Edinburgh (United King-
dom), while wild-type C57Bl/6J mice were obtained from
the Broekman Institute BV, Someren (The Netherlands).
The mice were kept in a controlled light–dark cycle. Food
and water were supplied ad libitum. Heterozygous TG-
TKT2 females were mated with wild-type males. The day
a plug was detected was destined day 1 of gestation (ED1).
Transgenic mice were identified by PCR analysis. The
forward primer was 5V-GCG TTC GGT CAG GCT GCT
CGT GC-3V and the reversed primer 5V-GCC AGT AAG
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a length of 234 bp. For control embryos and neonates,
nontransgenic C57Bl/6J male and female mice were used.
All animal experiments were carried out in accordance with
the guidelines of the local Animal Research Committee.
Embryonic day 14 (ED14), ED16, and ED18 embryos
were delivered by caesarian section. Embryos were fixed
after death by cooling on ice. Neonatal day 1 (ND1) and
ND7 animals were fixed after decapitation, removal of the
skin, and opening of the thorax for optimal penetration of
the fixative. Heart and lungs of ND14 and ND28 animals
were removed en bloc from the body before fixation. All
tissues were fixed at 4jC in 4% phosphate-buffered form-
aldehyde (w/v) for 16–18 h, dehydrated in a graded series
of ethanol, cleared with 1-butanol, and embedded in Para-
plast Plus (Monoject, Kildare, Ireland). Serial 7 Am frontal
sections were cut and mounted onto RNAse-free 3-amino-
propyltriethoxysilane (Sigma A3648)-coated slides.
To ablate the maternal thyroid, nonpregnant female
transgenic TG-TKT2 mice were treated twice daily for 3
days with an intraperitoneal injection of ganciclovir (9-[1,3-
dihydroxy-2-propoxymethyl]guanine; CymveneR, Syntex
BV, Rijswijk, The Netherlands; 150 Ag Na-ganciclovir/g
body weight/injection), starting at least 2 weeks before
mating (Fig. 1 and Wallace et al., 1991). These mice were
designated as pretreated mice. Before treatment, blood
samples were taken under light ether anesthesia via an
orbital puncture. A blood sample from the caval vein was
taken at sacrifice. The levels of thyroxine (T4) were deter-
mined with a radioimmunoassay (courtesy Department of
Endocrinology, Academic Medical Center, Amsterdam).
Pregnant pretreated transgenic mice were treated twice dailyFig. 1. Schematic representation of ganciclovir treatment of transgenic (TG-TKT2
(ip) with 150 Ag ganciclovir/g body weight for 3 days (indicated by black arrows
hypothyroid transgenic females were mated. At days 13, 14, and 15 of gestation, th
by black arrows) to ablate the thyroidal follicle cells of the transgenic fetuses (TT
unaffected.with intraperitoneal injections of ganciclovir (150 Ag gan-
ciclovir/g body weight/injection) on ED13, ED14, and
ED15 to ablate the developing thyroids of transgenic
embryos (TT group), while leaving the thyroids of non-
transgenic fetuses unaffected (TNT group) (Fig. 1). Control,
nontransgenic mice were similarly treated before and during
pregnancy.
Immunohistochemistry
All antibodies except that against thyroglobulin were
obtained from Dr. J.A. Whitsett. A guinea pig polyclonal
antibody against rat SP-A, a rabbit polyclonal antibody
against mature bovine SP-B (R28031), and a rabbit poly-
clonal antibody against human pro-SP-C (R68514) were
applied at a dilution of 1:300, 1:2000, and 1:2000, respec-
tively, to 7 Am deparaffinized sections. For SP-A and for
SP-B and pro-SP-C, a Vectastain ABC peroxidase kit and a
Vector Elite ABC-DAB kit, respectively, were used to
detect antigen-antibody complexes (Zhou et al., 1996).
The enzymatic reaction product was enhanced with nickel
or cobalt to produce a black precipitate. Sections were
counterstained with nuclear fast red. Thyroglobulin anti-
body was provided by Dr. J.J.M. de Vijlder and used at a
dilution of 1:5000.
In situ hybridization
[a-35S]dCTP-labeled antisense probes for a-MHC, h-
MHC, SERCA-2a, and PLB were generated as described
before (Moorman et al., 1995). Plasmids containing mouse
SP-A and SP-C (both in pGEM3Z) and SP-B (in pBS-SKII)) mice. Adult TG-TKT2 females were twice daily injected intraperitoneally
). After 14 days, when the follicle cells in the thyroids were destroyed, the
e hypothyroid pregnant mice were again treated with ganciclovir (indicated
group), while leaving the thyroids of nontransgenic littermates (TNT group)
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Bruno et al., 1992; Glasser et al., 1990; Korfhagen et al.,
1992). [a-35S]dCTP-labeled antisense probes for SP-A, -B,
and -C were generated with T7 polymerase after lineariza-
tion of the plasmids with ApaLI, EcoRI, and HindIII,
respectively. The hybridization conditions were as detailed
elsewhere (Moorman et al., 2000a). Exposure time to
nuclear autoradiographic emulsion (Ilford Nuclear Research
Emulsion G-5) was 14 days for SP-A and 7 days for SP-B
and -C. The development time was 4 min. After develop-
ment, the sections were dehydrated in a graded series of
ethanol and xylol and mounted in Malinol (Chroma-Gesell-
shaft, Schmidt Gmbh+Co, Ko¨ngen, Germany).
Image acquisition and analysis
For image acquisition, a Photometrics cooled CCD
camera (Tucson, AZ, USA; 12-bit dynamic range; 1317 
1035 pixels), attached to an Axioplan microscope (CarlFig. 2. Effectiveness of ganciclovir treatment. Thyroid glands were stained for the
mice. In control adult (panel A1) and ED16 mice (panel B1), numerous follicles we
mice (panel B2), most follicles had disappeared, leaving a disorganized thyroid
ganciclovir treatments decreased plasma thyroxine (T4) levels more than threefold
(TT group, panel D, left animal, 4 weeks old) were hypothyroid and failed to th
group) that also lacked maternal TH but had normal fetal and neonatal thyroid fuZeiss, Oberkochen, Germany) equipped with a 5 objective
(N.A.: 0.15), a stabilized power supply, and an infrared-
blocking filter was used. The low-power objective was used
to assure the sampling of several respiratory acini in an
image, representing 2.5 mm2 of the lung section. Digital
images from the in situ hybridization procedure were
recorded using white light (Jonker et al., 1997). The digital
transmission images were converted to optical density (OD)
images by calculating the negative logarithm of the trans-
mission image divided by an image of the light source
[OD = 10log(I / I0) for each pixel]. This conversion
implicitly corrects background shading.
The OD images were analyzed using the public domain
image analysis program NIH Image (rsb.info.nih.gov/nih-
image; version 1.61). The areas to be measured were
marked by an interactive density slice, which identifies
structures based on a selected lower and upper density
value. Tissue background was defined as nonstaining tissue
such as esophagus or cartilage tissue. Signal was defined aspresence of thyroglobulin in control and ganciclovir-treated transgenic (TT)
re present. In ganciclovir-treated transgenic (TT) adult (panel A2) and ED16
with few, usually large follicles behind in the adult. The two consecutive
in female transgenic mice (panel C). Ganciclovir-treated transgenic neonates
rive when compared to ganciclovir-treated nontransgenic littermates (TNT
nction (panel D, right animal, 4 weeks old).
Fig. 3. Effect of prenatal hypothyroidism on myosin heavy chain (MHC) and sarcoplasmatic reticulum ATPase (SERCA-2a) gene expression in the heart. The
control ventricle switched from expressing h-MHC (panel A, subpanels A–C) before birth to expressing a-MHC (panel B, subpanels A–C) shortly after birth.
Meanwhile SERCA-2a expression was up-regulated (panel C, subpanels A–C). In ganciclovir-treated transgenic (hypothyroid) offspring of hypothyroid
transgenic mothers (TT group), h-MHC expression was maintained postnatally (panel A, subpanels D–F), whereas a-MHC expression (panel B, subpanels
D–F) and SERCA-2a expression (panel C, subpanels D–F) were not up-regulated. Note that h- and a-MHC expression, as well as SERCA-2a expression in
the hearts of ganciclovir-treated nontransgenic (euthyroid) offspring of hypothyroid transgenic mothers (TNT group) behaved similarly to that in their
hypothyroid transgenic littermates (TT group) (panels A–C, subpanels G–I). Ganciclovir treatment of wild-type mice did not affect h-, a-MHC, or SERCA-2a
mRNA levels in the heart (panel D, ND28 hearts). Tissue mRNA staining was recorded and digital transmission images were converted to optical density (OD)
images.
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alveolar epithelium or myocardium) (Jonker et al., 1997;
Moorman et al., 2000a). The definitive signal value,
expressed as mean optical density (mean OD), is obtained
by subtracting the mean tissue background density from the
mean signal density (Jonker et al., 1997; Moorman et al.,
2000a). The positive signal is plotted as mean OD (FSEM)
per group and age. The volume fraction of SP mRNA-
expressing cells (% Area) was calculated from the area of
positive staining cells in the section and the total lung area
(excluding airspaces). All lung measurements were carried
out three times with a randomized series of images. No
differences were observed between the three measurements,
and therefore a mean value per lung was calculated. For the
heart, the resulting specific OD values are displayed using alook-up table that indicates the intensity of the positive
signal as fold tissue background.
Lung morphometry
Sections stained with hematoxylin and azophloxine were
analyzed as described (Hedrick et al., 1997). Digital images
were recorded with a high resolution CCD-color camera
(DXC-151, Sony Inc., Park Ridge, NJ, USA) attached to a
Microphot-FXA microscope (Nikon Inc., Melville, NY,
USA) equipped with a 40 objective. The video image
was overlain with a 42-point equidistant counting grid,
calibrated with an individual probe length line Z, where
Z = 20 Am. Lungs from control and TT mice were evaluated
and analyzed in a blinded manner.
M. van Tuyl et al. / Developmental Biology 272 (2004) 104–117110Volume fractions were established by counting test points
falling on airspaces (volume fraction of airspaces: VValv) and
alveolar septa (volume fraction of airspace walls: VVsept).
Airspace number per unit volume (NV) was calculated from
the formula NV = K (NA)
3/2 / b (VValv)
1/2, where K is the size
distribution coefficient (taken to be 1), b = 1.55, from the
Weibel and Gomez shape constant, and NA is the number of
airspaces (Nalv) per unit area of the counting grid (AT =
15,129 Am2). Average airspace volume (AAV) was estima-
ted from the following formula: AAV = (VValv) / (NV).
Alveoli were defined as closed airspaces divided by septa
in the periphery of the lung.
Statistics
In situ hybridization
Variation in staining intensity due to the different in situ
hybridization sessions was removed by subtracting the
session effects calculated from the log-transformed data
with the general linear model analysis of variance (ANOVA)
without interaction (SPSS version 10.0.7; SPSS Inc., Chi-
cago, IL, USA). Differences between treatment and age
groups (two animals per group per age) were tested with a
two-way ANOVA. Because of significant age  treatment
interactions, a one-way ANOVA per age group was carried
out to determine which groups differed at that age.
Lung morphometry
Results are expressed as mean F SEM (two animals per
group per age). Statistical analysis of the morphometric data
was performed using the unpaired t test, with P < 0.05
considered significant.Results
Transgenic dams were treated with ganciclovir before
pregnancy to ablate their thyroids as well as during preg-
nancy to ablate the thyroids of their transgenic fetuses
(Fig. 1). In this study, three groups of fetuses and neonates
were studied. The treated transgenic (TT) group included
transgenic offspring from transgenic mothers. The mothers
were made hypothyroid before pregnancy and the fetal
thyroids were ablated in utero. As a result, the TT group
lacked exposure to maternal and their own thyroid hormone.
The treated nontransgenic (TNT) group included the non-
transgenic littermates of the TT animals. The thyroids of
TNT mice were not destroyed upon ganciclovir treatment,
and as a result TNT mice lacked exposure to maternal
thyroid hormone only (Wallace et al., 1994). The control
animals were offspring from nontransgenic dams and were
hence exposed to both maternal and their own thyroid
hormone, as well as to ganciclovir.
The efficacy of the ganciclovir treatment protocol, which
was developed by Wallace et al. (1991), was assessed bystaining the thyroid remnants for the presence of thyroglo-
bulin (Fig. 2). In control adult animals (panel A1) and
fetuses (panel B1), strong staining for thyroglobulin was
seen in the follicle cells of the thyroid. In the TT animals,
the structure of the thyroid was disrupted and thyroglobulin
staining was dramatically decreased and only seen in some
remaining large follicles (panels A2 and B2). In accordance
with these findings, blood T4 levels in adult transgenic
animals decreased from 41 nmol/l before ganciclovir treat-
ment to 12 nmol/l 2 weeks after treatment (Fig. 2C). Finally,
the ganciclovir-treated hypothyroid neonates (TT group)
clearly lagged behind in growth compared to their non-
transgenic littermates (TNT group) (Fig. 2D).
Heart
We studied heart development in control and transgenic
mice at ED18, ND1, ND7, ND14, and ND28.
Myosin heavy chain mRNA
In ED18 hearts, h-MHC was strongly and similarly
expressed in the ventricles of control, TT, and TNT fetuses
(Fig. 3A, panels A, D, and G). By ND1, h-MHC expres-
sion had decreased dramatically in the control group (panel
B) and had become all but detectable at ND28 (panel C). In
neonatal TT ventricles however, h-MHC expression
remained unchanged (panel E). Moreover, h-MHC gene
expression did not decrease in TNT neonates (panel H). At
ND28, both TT and TNT animals still showed strong h-
MHC expression in their ventricles (panels F and I).
Ganciclovir treatment of wild-type embryos did not affect
postnatal h-MHC expression in the heart (Fig. 3D, panels
A and D).
In ED18 hearts, a-MHC expression in the ventricles was
relatively low in all groups (Fig. 3B, panels A, D, and G).
At ND1, a-MHC expression was up-regulated in the ven-
tricular myocardium of controls (panel B) and remained
high thereafter (panel C). In TT and TNT neonates however,
a-MHC expression did not increase (panels E and H) but
instead had even decreased by ND28 (panels F and I).
Ganciclovir treatment of wild-type embryos did not prevent
postnatal a-MHC expression in the heart (Fig. 3D, panels B
and E).
Sarcoplasmatic reticulum ATPase-2a and phospholamban
mRNA
In control mice, ventricular SERCA-2a mRNA levels
were lower before than 1 day after birth (Fig. 3C, panels A
and B). By ND28, SERCA-2a levels had increased only
marginally compared to ND1 (panel C). In hypothyroid TT
mice, ventricular SERCA-2a did not increase after birth
(panel E) and had even decreased by ND28 (panel F). In
the TNT neonates, SERCA-2a mRNA levels had increased
slightly at ND1 (panel H), but as in the TT mice, subse-
quently declined (panel I). Phospholamban mRNA levels
slightly increased perinatally in all groups (not shown), but
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not decline in the next 4 weeks in the TT and TNT groups
(not shown). Ganciclovir treatment of wild-type embryos did
not affect fetal or postnatal SERCA-2a (Fig. 3D, panels C
and F) or PLB (not shown) expression in the heart.
Lung
We studied lung development in control and transgenic
mice at ED14, ED16, ED18, ND1, ND7, ND14, and ND28.Before birth, the experimental groups showed only marginal
differences. ND7 and ND14 mice have intermediate staining
patterns for the different surfactant proteins between ND1
and ND28 (not shown).
Surfactant protein mRNA
SP-A mRNA was undetectable at ED14, but its cellular
concentration (mean OD) rapidly increased in the epithe-
lial cells of the lung in all three groups between ED16
and ND1 (Fig. 4A, full lines). After ND1, the cellular
concentration of SP-A mRNA declined in the control and
TNT groups, while it remained high in the TT group (Fig.
4A, full lines; one-way ANOVA for difference between
groups at ND28: P = 0.059). The volume fraction of cells
(% area) expressing SP-A mRNA was similar between all
three groups (Fig. 4A, interrupted lines). Prenatally (not
shown) and during the first postnatal week (Fig. 5, panels
A–C), SP-A mRNA expression was confined to alveolar
epithelial cells. In control animals, SP-A mRNA expres-
sion subsequently became concentrated in bronchiolar
epithelial cells (Fig. 5, panel D). However, in TT (Fig.
5, panel E) and TNT lungs (Fig. 5, panel F), SP-A
mRNA remained abundantly expressed throughout the
alveolar epithelium, while expression in bronchiolar epi-
thelial cells remained less pronounced than in the control
animals. The SP-A protein staining intensity was compa-
rable among control, TT, and TNT lungs at ND28 (Fig. 5,
panels G–I). Note, however, that the alveolar spaces in
TT animals were much larger than in control or TNT
animals, indicating abnormal structural development of
TT lungs.
Before birth, the cellular concentration (mean OD) of
SP-B mRNA increased similarly in all groups (Fig. 4B,
full lines). However, in ND1 neonates, the cellular con-
centration for SP-B mRNA was significantly lower in the
TT group than in the control or TNT groups (Fig. 4B, full
lines). Due to a steep decline in SP-B mRNA content in
control lungs, the SP-B mRNA content in TT and TNT
lungs became significantly higher than in controls at ND7Fig. 4. Quantification of SP-A, -B, and -C mRNA levels in perinatal lungs.
Cellular concentrations (mean OD) of SP-A, -B, and -C are shown in panels
A, B, and C, respectively. Mean ODs were determined by quantification of
the in situ hybridization signal in the alveolar and bronchiolar epithelium,
while the volume fraction of cells (% area) expressing SP mRNA was
calculated as a percentage of total lung tissue (staining and nonstaining
tissue, excluding airspaces). The light absorption by the resulting silver
grains and the volume fraction SP mRNA-positive cells are expressed on
the y-axis as mean OD (full lines) and % area (interrupted lines),
respectively. TT mice are ganciclovir-treated transgenic (hypothyroid) offs-
pring of hypothyroid transgenic mothers, whereas TNT mice are the non-
transgenic littermates that also lacked maternal TH but had their own fetal
and neonatal thyroid function. For mean OD: SP-A: one-way ANOVA at
ND28: P = 0.059. SP-B: one-way ANOVA at ND7 and ND28: both P <
0.05. SP-C: P = 0.01 at ND28. The volume fraction of SP mRNA-positive
cells (% area) did not differ between the three groups except at ND7 in the
TNT group.
Fig. 5. SP-A expression in neonatal lungs. Lungs of control animals (panels A, D, and G), ganciclovir-treated transgenic (hypothyroid) offspring of hypothyroid
transgenic mothers (TT group; panels B, E, and H), and their nontransgenic littermates that lacked maternal TH but had their own fetal and neonatal thyroid
function (TNT group; panels C, F, and I) at ND1 (panels A–C) and ND28 (panels D–I). Panels A–F were stained for the presence of SP-A mRNA, whereas
panels G–I were stained for the presence of SP-A protein. Note the increased SP-A mRNA expression in alveolar epithelium of TT and TNT lungs (panels E
and F, respectively) compared to control lungs (panel D) at ND28 and comparable SP-A protein staining intensity between the three groups (panels G–I). ‘‘B’’
represents bronchiole. Arrows (panels G–I) indicate SP-A-positive cells. Scale bar: (A–F) 200 Am and (G–I) 50 Am.
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postnatally (Fig. 6, panels A–C), SP-B mRNA was present
in both alveolar and bronchiolar epithelium of all groups.
Bronchiolar SP-B mRNA levels were similar between the
three groups, whereas alveolar SP-B mRNA expression
remained high in TT and TNT lungs (Fig. 6, panels E and
F) when compared to controls (Fig. 6, panel D). The
volume fraction of SP-B-positive cells (% area) was
similar in all groups (Fig. 4B, interrupted lines). Also,
the staining intensity for SP-B protein was similar in all
groups at all the gestational ages investigated (Fig. 6, panel
G–I).
SP-C mRNAwas already detectable in ED14 lungs (Fig.
4C, full lines). At that age, SP-C mRNAwas only expressed
in alveolar epithelial cells and this expression pattern
remained unchanged throughout lung development in all
three groups (Fig. 7, panels A–F). A pronounced decline in
the cellular concentration (mean OD) of SP-C mRNA was
observed in neonatal controls, whereas the mean OD for SP-
C mRNA in the TT group remained high, with the TNT
group occupying an intermediate position (Fig. 4C, full
lines) (one-way ANOVA at ND28: P = 0.01). The volume
fraction of cells (% area) expressing SP-C mRNA was
similar in all groups except at ND7 in the TNT group
(Fig. 4C, interrupted lines). After birth, the staining intensity
for SP-C pro-protein was always lower in TT lungs (Fig. 7,panel H) than in control or TNT lungs (Fig. 7, panels G and
I, respectively).
Structural development
The morphometric analysis was carried out for the TT
(hypothyroid) and the control groups only. Morphologically,
there were no gross differences between control and hypo-
thyroid lungs before birth. However, after birth, when the
alveolar phase of lung development takes place, the hypo-
thyroid lungs showed progressively larger airspaces, with
less alveolar septae compared to control and TNT lungs
(Figs. 5–7; compare panels H (TT group) with panels G
(control group) and I (TNT group). No evidence of hemor-
rhage or inflammation was observed in either group. Three
morphometric parameters were used to quantify the mor-
phologic differences between control and hypothyroid
lungs: the number of airspaces per unit volume (NV), the
volume fraction of septa (VVsept), and average airspace
volume per Am3 (AAV). NV was significantly reduced in
postnatal hypothyroid lungs (Fig. 8A). At the same time, the
AAV of an individual hypothyroid airspace was three- to
fourfold larger than in comparable control lungs (Fig. 8B).
Together with the two- to threefold decrease in the contri-
bution of VVsept in hypothyroid lungs (Fig. 8C), these data
show that the postnatal hypothyroid animals have decreased
alveolar septation resulting in large saclike alveoli that
Fig. 6. SP-B expression in neonatal lungs. Lungs of control animals (panels A, D, and G), ganciclovir-treated transgenic (hypothyroid) offspring of hypothyroid
transgenic mothers (TT group; panels B, E, and H), and their nontransgenic littermates that lacked maternal TH but had their own fetal and neonatal thyroid
function (TNT group; panels C, F, and I) at ND1 (panels A–C) and ND28 (panels D–I). Panels A–F were stained for the presence of SP-B mRNA, whereas
panels G–I were stained for the presence of SP-B protein. Note the increased SP-B mRNA expression in the alveolar epithelium of TT and TNT lungs (panels
E and F, respectively) when compared to control lungs (panel D) at ND28 and decreased SP-B mRNA expression in TT lungs at ND1 (panel B). SP-B protein
staining intensity was comparable between the three groups (panels G–I). ‘‘B’’ represents bronchiole. Scale bar: (A–F) 200 Am and (G–I) 50 Am.
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septation suggests an important role for thyroid hormone in
the postnatal structural maturation of the lungs.Discussion
The importance of a functioning thyroid gland for normal
postnatal development is clear from the severe mental
retardation that develops in newborns with congenital hy-
pothyroidism (Foley, 2000). If T4 supplementation is started
within 2 weeks after birth, the athyroid newborn is com-
pletely rescued from neurological damage (Bongers-Schok-
king et al., 2000; van Vliet, 2001). Such data have suggested
that the availability of thyroid hormone to the fetus was of
minimal importance for normal prenatal development. The
high deiodinase type III activity of the placenta (Burrow et
al., 1994; Koopdonk-Kool et al., 1996; Santini et al., 1999),
together with the very low circulating T3 level in the fetus
(Polk, 1995), supported this line of thought. Nevertheless,
the neurological cretinism that results from severe iodine
deficiency during early pregnancy (Cao et al., 1994;
Delange, 2001) clearly demonstrates that thyroid hormone
does play an important role in the normal development of
most vertebrate tissues, in particular the brain (Porterfield
and Hendrich, 1993). Because T4 was shown to be present
in the fetus before the fetal thyroid is capable of producingit, it was concluded that thyroid hormone of maternal origin
could pass the placenta despite the high deiodinase activity
in this organ (Vulsma et al., 1989). More recently, it was
further demonstrated that (subclinical) maternal hypothy-
roidism during early pregnancy can cause neurological
deficits in the offspring, even when the mother and offspring
are euthyroid at birth (Haddow et al., 1999; Morreale de
Escobar et al., 2000; Pop et al., 1999).
Based on the outcome of these studies, we wondered
whether maternal hypothyroidism during early pregnancy
might also affect the postnatal development of organs other
than the brain, that is, heart and lungs. We chose the TG-
TKT2 transgenic mouse model as described by Ellison et al.
(1995) to investigate this question. We demonstrated that
also in our hands the administration of ganciclovir to these
transgenic mice resulted in an almost complete destruction
of the thyroidal follicle cells and a dramatic decrease in
circulating T4 levels. The earlier conclusion that T4 levels
became undetectable after ganciclovir treatment of these
mice (Wallace et al., 1991) was due to the lower sensitivity
of the assay used at the time. With the same assay, circula-
ting T4 was below the limit of detection in TT pups, whereas
that in TNT littermates was normal (Wallace et al., 1994).
Our study showed that in the heart, the neonatal switch
from h-MHC to a-MHC expression in the cardiac ventricles
did not occur in either the TT (thyroid destroyed) or TNT
(intact thyroid) group, even though thyroid-hormone pro-
Fig. 7. SP-C expression in neonatal lungs. Lungs of control animals (panels A, D, and G), ganciclovir-treated transgenic (hypothyroid) offspring of hypothyroid
transgenic mothers (TT group; panels B, E, and H), and their nontransgenic littermates that lacked maternal TH but had their own fetal and neonatal thyroid
function (TNT group; panels C, F, and I) at ND1 (panels A–C) and ND28 (panels D–I). Panels A–F were stained for the presence of SP-C mRNA, whereas
panels G–I were stained for the presence of SP-C pro-protein. Note the increased SP-C mRNA expression in the alveolar epithelium of TT and TNT lungs
(panels E and F, respectively) compared to control lungs (panel D) at ND28 and decreased SP-C mRNA expression at ND1 in TT lungs (panel B). SP-C pro-
protein staining intensity was less in TT lungs (panel H) compared to control and TNT lungs at ND28 (panels G and I, respectively). ‘‘B’’ represents
bronchiole. Scale bar: (A–F) 200 Am and (G–I) 50 Am.
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Similarly, SERCA-2a expression declined postnatally in the
TT and TNT groups compared to controls, although the
effect was less pronounced in the TNT than in the TT group.
Tissue architecture of perinatal hearts was not affected by the
experimental conditions. Similarly, lung development up to
the saccular phase (ED18-ND5) was not affected by maternal
or fetal hypothyroidism. Our histological data (Figs. 5–7,
panels G–I, and Fig. 8), in conjunction with those in the
hypothyroid ‘‘hyt’’ mouse model (Beamer et al., 1981), do
indicate however that alveolar formation, that is, postnatal
lung development, was affected by postnatal thyroid-hor-
mone deficiency. In agreement with the largely normal
structural development of the lungs in control, TT, and
TNT fetuses, we did not observe differences in prenatal SP
expression between these groups. After birth, the cellular
concentration of SP-A, -B, and -C mRNA remained high in
the alveolar epithelium of TT and, to a lesser extent, of TNT
lungs compared to control lungs. Had we related the levels of
gene expression to a global tissue base, such as organ weight
or protein content, the altered expression pattern of SP-A and
-B in the distal epithelium of the hypothyroid animals would
have escaped our attention. This finding underlines the
suitability of the quantitative in situ hybridization technique
to measure differences in cellular mRNA concentration in
the context of both the changing tissue architecture and thechanging topographic pattern of a gene expression (Jonker et
al., 1997; Moorman et al., 2000a; Ruijter et al., 2001).
Despite high cellular SP mRNA levels, the staining intensity
for the corresponding proteins was not increased. In perinatal
liver, like the lungs, a derivate of the embryonic foregut, such
comparatively high mRNA–protein ratios reflect immaturity
(Lamers et al., 1999). Together, these data indicate that
alveolar morphogenesis is sensitive to postnatal thyroid
hormone deficiency, but that tissue maturation as reflected
by cellular SP mRNA concentrations is, in addition, also
affected by embryonic thyroid hormone deficiency.
These observations confirm earlier claims that thyroid
hormone is an important determinant for perinatal lung
development (Holt et al., 1993; Massaro et al., 1986) but
at the same time demonstrate that the effects of hypothy-
roidism on lung development are virtually undetectable
before birth and only become overt after birth. Also, our
results demonstrate that hypothyroidism (maternal and/or
fetal) does result in the maintenance of relatively high
mRNA concentrations and high SP mRNA–protein ratios
for all three SPs and no evidence for an SP-A and -B
deficiency after birth. These findings may therefore explain
the lack of effect of prenatal thyroid hormone treatment to
prevent postnatal respiratory distress syndrome (ACTOBAT,
1995; Ballard et al., 1998). The limited role of thyroid
hormone in prenatal heart and lung development is also
Fig. 8. Morphometry of neonatal lungs. The number of airspaces per unit
volume (NV, panel A), the volume fraction of septa (VVsept  102, panel B),
and the average airspace volume per Am3 (AAV  104, panel C) in control
mice (light bars) and in ganciclovir-treated transgenic (hypothyroid)
offspring of hypothyroid transgenic mothers (TT group, dark bars) were
determined at ND1, ND7, and ND28. At ND7 and ND28, hypothyroid mice
showed a statistically significant increase in AAV and a statistically
significant decrease in VVsept and NV compared to control mice, indicating
the presence of poorly septated lungs with large alveoli in postnatal
hypothyroid mice. At ND7 and ND28, NV, VVsept, and AAV of TT mice
differ from those in wild-type mice ( P < 0.05).
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of mice that are devoid of all known thyroid hormone
receptors (Go¨the et al., 1999).
Our key finding that nontransgenic neonates (with intact
thyroids) from hypothyroid mothers have a similar early
postnatal phenotype as their transgenic littermates (with
destroyed thyroids) is remarkable. Our observations do not
distinguish in the nontransgenic neonates (intact thyroid)
between a hypothyroid state and a euthyroid state with
‘‘peripheral’’ resistance to thyroid hormone as a result of
maternal hypothyroidism. However, several observations
argue in favor of the second mechanism. At 3 weeks after
birth, transgenic pups (destroyed thyroid) from ganciclovir-
treated dams had undetectable levels of T4, while their
nontransgenic littermates (intact thyroid) had normal T4
levels (Wallace et al., 1994). Also, growth during the first
10 days after birth was dominated by the T4 status of the
dam during gestation (Wallace et al., 1995). Likewise, the
brains of wild-type pups that were born to hypothyroid TG-
TKT2 dams were just as deficient in oligodendrocytes as the
brains of their hypothyroid transgenic littermates (Ahlgren
et al., 1997), suggesting that maternal thyroid hormone acts
early in pregnancy to influence oligodendrocyte develop-
ment and that the consequences of deprivation of thyroid
hormone early in pregnancy on postnatal oligodendrocytedevelopment are not reversed by thyroid-hormone produc-
tion in the fetal thyroid. Similarly, administration of inhi-
bitors of thyroid-hormone synthesis to dams before and
during early pregnancy suppressed neuroendocrine-specific
protein (NSP-A) expression in the fetal brain cortex before
the onset of thyroid function in the rat fetus on gestational
day 17 (Dowling et al., 2001).
A conceptual context for the development of a euthyroid
state with peripheral resistance to thyroid hormone as a
result of maternal hypothyroidism became available when it
was shown that expression of a-internexin persists in
euthyroid fetuses born to hypothyroid (thyroidectomized)
dams, but not in those born to euthyroid dams (Sampson et
al., 2000). a-Internexin is the first neuronal intermediate
filament to be expressed in newly differentiating neurons
and constitutes the major neural intermediate filament
before the onset of fetal thyroid hormone secretion. Failure
of a-internexin to decline in late fetal life may have serious
consequences if not corrected soon after birth, since over-
expression of a-internexin in transgenic mice is associated
with deficits in motor coordination (Sampson et al., 2000).
Together, these findings show that the fetal thyroid is not
able to rescue the deleterious effects of early maternal
hypothyroidism and argue in favor of a euthyroid state with
peripheral thyroid hormone resistance rather than a defi-
ciency of thyroid hormone itself in postnatal offspring with
an intact thyroid that are born to hypothyroid dams.
A rescue experiment with thyroid hormone supplementa-
tion to the pregnant dam would have added elegance to our
arguments. However, such a rescue experiment is not
straightforward since it appears almost impossible to predict
T4 levels in a fetus upon T4 administration to the dam.
Infusion of T4 into methimazole-treated hypothyroid dams
resulted in maternal euthyroidism, but fetal plasma T4 did not
exceed 40% of normal and plasma TSH remained high
(Calvo et al., 1990). Titration of T4 over time was also
difficult in such rats because serum T4 levels initially stayed
rather low during T4 substitution but then increased rapidly
but transiently, with TSH remaining high despite T4 substi-
tution (Dowling et al., 2000). Moreover, when T4 levels
normalized, T3 levels remained low and TSH levels elevated,
while the transport of T4 from plasma to organs was de-
creased in pregnant thyroidectomized rats compared to eu-
thyroid pregnant dams, even after thyroid hormone treatment
(Versloot et al., 1998). In our view, a rescue experiment with
T4 is therefore complex and may not produce clear answers.
It is obvious that thyroid hormone deficiency is more
detrimental to a developing organism than a deficiency of
nuclear thyroid hormone receptors (Cao et al., 1994; Gauth-
ier et al., 1999; Go¨the et al., 1999). This conclusion suggests
that the detrimental effect of maternal thyroid hormone
deficiency on the fetus is caused by a biological effect of
thyroid hormone nuclear receptors that are not occupied by
their ligand (Hashimoto et al., 2001) or alternatively does
not require thyroid hormone signaling via thyroid hormone
nuclear receptors. Additional possibilities are that the effect
M. van Tuyl et al. / Developmental Biology 272 (2004) 104–117116is mediated by a different isoform of the steroid hormone
nuclear receptor family, or that maternally derived thyroid
hormone determines the set point for the number and/or the
isoform of thyroid hormone receptors expressed in a deve-
loping organ. Based on our key finding that prenatal
deficiency of maternally derived thyroid hormone affects
postnatal responses in cardiac and pulmonary gene expres-
sion, we favor the first and last alternatives over the other
two possibilities.
Our finding that hypothyroidism during early develop-
ment does not impair organ morphogenesis but does affect
adaptive responses in gene expression in these organs
postnatally is especially important in the light of recent
studies that describe a negative effect of (undetected) mater-
nal hypothyroidism on brain development (Haddow et al.,
1999; Morreale de Escobar et al., 2000; Pop et al., 1999). A
free T4 concentration below the 10th percentile at 12 weeks
gestation was a significant risk factor for impaired psycho-
motor development of the children at 10 months of age (Pop
et al., 1999). Furthermore, children born to women with an
undiagnosed (mild) hypothyroidism performed less well on
IQ tests at 7–9 years of age (Haddow et al., 1999). Accor-
dingly, we hypothesize that maternal hypothyroidism also
causes changes in gene expression in fetal heart and lung that
cannot be reversed by fetal and/or neonatal thyroid hormone.Acknowledgments
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